Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
Details for 2019210527
Up to date per 04.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2019210527
Title / Product Name
VERFAHREN ZUR BEHANDLUNG VON KREBSPATIENTEN MIT FARNESYL-TRANSFERASE-INHIBITOREN
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2019210527
EP Publication Number
3640345
E-Number
1436278
Language
EN
PCT Number
Publication Date
22.04.2020 A
06.10.2021 B1
Registration Date
06.10.2021
AT Publication Date
15.10.2021
Application Date
16.08.2016
Registration Number
-
Priorities
17.08.2015
US
201562206194 P
15.09.2015
US
201562218927 P
13.10.2015
US
201562241019 P
18.03.2016
US
201662310582 P
09.08.2016
US
201662372662 P
IPC
C12Q 1/6886 20180101AFI20210330BHEP
Maximum Duration of Protection
16.08.2036
Owner
Kura Oncology, Inc.
12730 High Bluff Drive, Suite 400
San Diego, CA 92130
US
Representative
Representative
Schwarz & Partner Patentanwälte GmbH
Wipplingerstraße 30
1010 Wien
AT
Inventor
GUALBERTO, Antonio
8 Larch Road
Acton, MA Massachusetts 01720
US
SCHOLZ, Catherine Rose
8 James Millen Road
North Reading, MA Massachusetts 01864
US